This effect was attenuated in the presence of an ERK5 inhibitor, indicating NPY-mediated active de novo lipogenesis in Y5Rhigh-tumor cells through an ERK5/SREBP2-dependent mechanism, consistent with existing literature highlighting Y5R involvement in mediating lipogenesis145. This evidence concerns the gene SREBF2 and neoplasm.